Attenuation of ethanol withdrawal syndrome by extract of Hypericum perforatum in Wistar rats

Fundamental and Clinical Pharmacology

Volumn 20, Issue 5, 2006, Pages 481-488

  Coskun, Ilke ^a   Tayfun Uzbay, I ^b   Ozturk, Nilgun ^a   Ozturk, Yusuf ^a  

^a ANADOLU UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Ethanol; Ethanol withdrawal; Hypericum perforatum; Rat(s); St John's wort

Indexed keywords

ALCOHOL; HYPERICUM PERFORATUM EXTRACT;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDIOGENIC SEIZURE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SYNTHESIS; HYPERACTIVITY; LOCOMOTION; MALE; MOTOR COORDINATION; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY; TREMOR; WEIGHT CHANGE;

ANIMALS; BEHAVIOR, ANIMAL; ETHANOL; HYPERICUM; HYPERKINESIS; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR; SUBSTANCE WITHDRAWAL SYNDROME; TREMOR;

EID: 33748695370     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2006.00432.x     Document Type: Article

References (51)

1. Butterweck V., Wall A., Lieflander-Wulf U., Winterhoff H., Nahrstedt A. Effects of total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry (1997) 30(Suppl.), 117-124.
2. Ozturk Y. Testing the antidepressant effects of hypericum species on animal models. Pharmacopsychiatry (1997) 30(Suppl.), 125-128.
3. De Vry J., Maruel S., Schreiber R., de Beun R., Jentzsch K.R. Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism. Eur. Neuropsychopharmacol. (1999) 9 461-468.
4. Linde K., Ramirez G., Mulrow C.D., Pauls A., Weidenhammer W., Melchart D. St John's wort for depression - an overview and meta-analysis of randomized clinical trials. Br. Med. J. (1996) 313 253-258.
5. Melchart D. St John's wort for depression - an overview and meta-analysis of randomized clinical trials. Br. Med. J. (1996) 313 241-242.
6. Volz H.P. Controlled clinical trials of hypericum extracts in depressed patients - an overview. Pharmacopsychiatry (1997) 30(Suppl.), 72-76.
7. Kasper S., Dienel A. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology (2002) 164 301-308.
8. Weissman M.M., Myers J.K. Clinical depression in alcoholism. Am. J. Psychiatry (1980) 137 372-373.
9. Miguel-Hidalgo J., Rajkowska G. Comparison of prefrontal cell pathology between depression and alcohol dependence. J. Psychiatr. Res. (2003) 37 411-420.
10. Kiianmaa K., Stenius K., Sinclair J.D. Determinants of alcohol preference in the AA and ANA rat lines selected for differential ethanol intake. Alcohol Alcohol. (1991) 26 115-120.
11. Overstreet D.H., Rezvani A.H., Janowsky D.S. Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. Biol. Psychiatry (1992) 31 919-936.
12. Rezvani A.H., Overstreet D.H., Yang Y., Clark E. Attenuation of alcohol intake by extract of Hypericum perforatum (St John's wort) in two different strains of alcohol-preferring rats. Alcohol Alcohol. (1999) 34 699-705.
13. Perfumi R., Ciccocioppo R., Angeletti S., Cucculelli M., Massi M. Effects of Hypericum perforatum extract on alcohol intake in Marchigian Sardinian alcohol-preferring rats. Alcohol Alcohol. (1999) 34 690-698.
14. 2 extract of Hypericum perforatum on alcohol intake in rats. Alcohol Alcohol. (2001) 36 199-206.
15. Perfumi M., Santoni M., Ciccocioppo R., Massi M. Blockade of γ-aminobutyric acid receptors does not modify the inhibition of ethanol intake induced by Hypericum perforatum in rat. Alcohol Alcohol. (2002) 37 540-546.
16. Wright C.W., Gott M., Grayson B. et al. Correlation of hyperforin content of Hypericum perforatum (St John's wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study. J. Psychopharmacol. (2003) 17 403-408.
17. 2 extract on the motivational properties of ethanol in alcohol-preferring rats. Alcohol Alcohol. (2005) 40 291-296.
18. O'Brien C.P. Drug addiction and abuse, in: Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., Gilman A.G. (Eds), Goodman and Gilman's The pharmacological basis of therapeutics, McGraw-Hill, New York, 1996, pp. 557-577.
19. Majchrowicz E. Induction of physical dependence upon ethanol and associated behavioral changes in rats. Psychopharmacologia (1975) 43 1993-1996.
20. Miller N.S. Pharmacotherapy in alcoholics. J. Addict. Dis. (1995) 14 23-46.
21. Myrick H., Brady K.T., Malcolm R. New developments in the pharmacotherapy of alcohol dependence. Am. J. Addict. (2001) 10(Suppl.), 3-15.
22. Uzbay I.T., Saglam E., Kayir H., Çelik T., Beyazyurek M. Effects of fluoxetine on ethanol withdrawal syndrome in rats. J. Psychiatr. Res. (2004) 38 445-450.
23. Saglam E., Uzbay I.T., Kayir H., Çelik T., Beyazyurek M. Effects of venlafaxine on ethanol withdrawal syndrome in rats. Fundam. Clin. Pharmacol. (2004) 18 693-698.
24. Uzbay T., Kayir H., Çelik T., Yuksel N. Acute and chronic tianeptine treatments attenuate ethanol withdrawal syndrome in rats. Prog. Neuro-Psychopharmacol. Biol. Psychiat. (2006) 30 478-485.
25. Uzbay I.T., Kayaalp S.O. A modified liquid diet of chronic ethanol administration: validation by ethanol withdrawal syndrome in rats. Pharmacol. Res. (1995) 31 37-42.
26. Ozturk Y., Aydin S., Beis R., Başer K.H.C., Berberoǧlu H. Effects of Hypericum perforatum L. and Hypericum calycinum L. Extracts on the central nervous system in mice. Phytomedicine (1996) 3 139-146.
27. Morriset R.A., Rezvani A.H., Overstreet D., Janowsky D., Wilson W.A., Swartzwelder H.S. MK-801 potently inhibits alcohol withdrawal seizures in rats. Eur. J. Pharmacol. (1990) 176 103-105.
28. Uzbay I.T., Kayaalp S.O. Heterogeneity of tolerance developed to effects of ethanol on rotarod and accelerod performances in rats. Alcohol (1995) 12 593-595.
29. Uzbay I.T., Erden B.F. Attenuation of ethanol withdrawal signs by high doses of L-arginine in rats. Alcohol Alcohol. (2003) 38 213-218.
30. Uzbay I.T., Erden B.F., Tapanyiǧit E.E., Kayaalp S.O. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci. (1997) 61 2197-2209.
31. Uzbay I.T., Celik T., Aydin A., Kayir H., Tokgoz S., Bilgi C. Effects of chronic ethanol withdrawal on cyclic guanosine 3′,5′-monophosphate (cGMP) levels in the rat brain. Drug Alcohol Depend. (2004) 74 55-59.
32. Uzbay I.T., Akarsu E.S., Kayaalp S.O. Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats. Pharmacol. Biochem. Behav. (1994) 49 969-974.
33. Uzbay I.T., Yeşilyurt Ö., Çelik T., Ergün H., Işimer A. Effects of agmatine on ethanol withdrawal syndrome in rats. Behav. Brain Res. (2000) 107 153-159.
34. Greeson J.M., Sanford B., Monti D.A. St John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology (2001) 153 402-414.
35. Schmidt U., Harrer G., Kuhn U., Berger-Deinert W., Luther D. Hypericum-extract mit alcohol. Nervenheilkunde (1993) 12 314-319.
36. Neary J.T., Bu Y. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res. (1990) 816 358-363.
37. Perovic S., Muller W.E.G. Pharmacological profile of hypericum extracts. Effect on serotonine uptake by postsynaptic receptors. Arzneim. Forsch. Drug Res. (1995) 45 145-148.
38. Cott J.M. In vivo receptor binding and enzyme inhibition by Hypericum perforatum extract. Pharmacopsychiatry (1997) 30(Suppl.), 108-112.
39. Bennet D.A., Phun L., Polk J.F., Voglino S.A., Zlotnik V., Raffa R.N. Neuropharmacology of St John's wort (Hypericum). Ann. Pharmacother. (1998) 32 1201-1208.
40. Calapai G., Crupi A., Firenzuoli F. et al. Effects of Hypericum perforatum on levels of 5-hydroxytriptamine, noradrenaline and dopamine in the cortex, diencephalons and brainstem of the rat. J. Pharm. Pharmacol. (1999) 51 723-728.
41. McBride W.J., Murphy J.M., Yoshimoto K., Lumeng L., Li T-K. Serotonin mechanisms in alcohol drinking behavior. Drug Dev. Res. (1993) 30 170-177.
42. Uzbay I.T., Usanmaz S.E., Tapanyiǧit E.E., Aynacioǧlu Ş., Akarsu E.S. Dopaminergic and serotonergic alterations in the rat brain during ethanol withdrawal: association with behavioral signs. Drug Alcohol Depend. (1998) 53 39-47.
43. De Witte P., Pinto E., Ansseau M., Verbanck P. Alcohol withdrawal: from animal research to clinical issues. Neurosci. Biobehav. Rev. (2003) 27 189-197.
44. Luo L., Sun Q., Mao Y.Y., Lu Y.H., Tan R.X. Inhibitory effects of flavonoids from Hypericum perforatum on nitric oxide synthase. J. Ethnopharmacol. (2004) 93 221-225.
45. Uzbay I.T., Coskun I., Kayir H., Ozturk N., Ozturk Y. St John's wort blocks caffeine-induced locomotor activity in mice. World J. Biol. Psychiatry (2005) 6(Suppl. 1), 310-311.
46. Hosseinzadeh H., Karimi G.-R., Rakhshanizadeh M. Anticonvulsant effect of Hypericum perforatum: role of nitric oxide. J. Ethnopharmacol. (2005) 98 207-208.
47. Adams M.L, Sewing B.N., Chen J., Meyer E.R., Cicero T.J. Nitric oxide-related agents alter ethanol withdrawal in male rats. Alcohol. Clin. Exp. Res. (1995) 19 195-199.
48. Lallemand F., De Witte P. L-NNA decreases cortical vascularization, alcohol preference and withdrawal in alcoholic rats. Pharmacol. Biochem. Behav. (1997) 58 753-761.
49. Uzbay I.T., Oglesby M.W. Nitric oxide and substance dependence. Neurosci. Biobehav. Rev. (2001) 25 43-52.
50. Wegener G., Volke V., Harvey B.H., Rosenberg R. Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Res. (2003) 959 128-134.
51. Calabrese E.J., Baldwin L.A. Hormesis: U-shaped dose responses and their centrality in toxicology. Trends Pharmacol. Sci. (2001) 22 285-291.